COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

por Zeng, Cong, Evans, John P., Chakravarthy, Karthik, Qu, Panke, Reisinger, Sarah, Song, No-Joon, Rubinstein, Mark P., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2022

Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021

Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8(+) T cell antitumor immunity

por Li, Anqi, Chang, Yuzhou, Song, No-Joon, Wu, Xingjun, Chung, Dongjun, Riesenberg, Brian P, Velegraki, Maria, Giuliani, Giuseppe D, Das, Komal, Okimoto, Tamio, Kwon, Hyunwoo, Chakravarthy, Karthik B, Bolyard, Chelsea, Wang, Yi, He, Kai, Gatti-Mays, Margaret, Das, Jayajit, Yang, Yiping, Gewirth, Daniel T, Ma, Qin, Carbone, David, Li, Zihai
Publicado 2022

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

por Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P.M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Publicado 2021

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

por Song, No-Joon, Allen, Carter, Vilgelm, Anna E., Riesenberg, Brian P., Weller, Kevin P., Reynolds, Kelsi, Chakravarthy, Karthik B., Kumar, Amrendra, Khatiwada, Aastha, Sun, Zequn, Ma, Anjun, Chang, Yuzhou, Yusuf, Mohamed, Li, Anqi, Zeng, Cong, Evans, John P., Bucci, Donna, Gunasena, Manuja, Xu, Menglin, Liyanage, Namal P. M., Bolyard, Chelsea, Velegraki, Maria, Liu, Shan-Lu, Ma, Qin, Devenport, Martin, Liu, Yang, Zheng, Pan, Malvestutto, Carlos D., Chung, Dongjun, Li, Zihai
Publicado 2022

Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy

por Azar, Joseph H., Evans, John P., Sikorski, Madison H., Chakravarthy, Karthik B., McKenney, Selah, Carmody, Ian, Zeng, Cong, Teodorescu, Rachael, Song, No-Joon, Hamon, Jamie L., Bucci, Donna, Velegraki, Maria, Bolyard, Chelsea, Weller, Kevin P., Reisinger, Sarah A., Bhat, Seema A., Maddocks, Kami J., Denlinger, Nathan, Epperla, Narendranath, Gumina, Richard J., Vlasova, Anastasia N., Oltz, Eugene M., Saif, Linda J., Chung, Dongjun, Woyach, Jennifer A., Shields, Peter G., Liu, Shan-Lu, Li, Zihai, Rubinstein, Mark P.
Publicado 2023